PURPOSE: Abnormal expression of miRNAs is closely related to a variety of human cancers. The purpose of this study is to identify new tumor suppressor miRNA and elucidate its physiological function and mechanism in renal cell carcinoma (RCC). METHODS: The expression of miR-145 in 45 RCC and adjacent normal tissues was performed by quantitative RT-PCR. Cell proliferation, migration, invasion, apoptosis and cycle assays were carried out for functional analysis after miR-145 transfection. Two target genes of miR-145 were identified by luciferase reporter assay. The altered expression of 84 epithelial to mesenchymal transition (EMT)-related genes after miR-145 transfection was detected by RT(2) Profiler EMT PCR array. RESULTS: The expression of miR-145 was downregulated in RCC compared to their normal adjacent tissues. Restoring miR-145 expression in RCC cell lines dramatically suppressed cell proliferation, migration and invasion, and induced cell apoptosis and G2-phase arrest. We further validated those miR-145 targets two oncogenes, ANGPT2 and NEDD9 in RCC. In addition, miR-145 was found to regulate numerous genes involved in the EMT. CONCLUSIONS: These findings demonstrate that miR-145 functions as tumor suppressor in RCC, suggesting that miR-145 may be a potential therapeutic target for RCC.
PURPOSE: Abnormal expression of miRNAs is closely related to a variety of humancancers. The purpose of this study is to identify new tumor suppressor miRNA and elucidate its physiological function and mechanism in renal cell carcinoma (RCC). METHODS: The expression of miR-145 in 45 RCC and adjacent normal tissues was performed by quantitative RT-PCR. Cell proliferation, migration, invasion, apoptosis and cycle assays were carried out for functional analysis after miR-145 transfection. Two target genes of miR-145 were identified by luciferase reporter assay. The altered expression of 84 epithelial to mesenchymal transition (EMT)-related genes after miR-145 transfection was detected by RT(2) Profiler EMT PCR array. RESULTS: The expression of miR-145 was downregulated in RCC compared to their normal adjacent tissues. Restoring miR-145 expression in RCC cell lines dramatically suppressed cell proliferation, migration and invasion, and induced cell apoptosis and G2-phase arrest. We further validated those miR-145 targets two oncogenes, ANGPT2 and NEDD9 in RCC. In addition, miR-145 was found to regulate numerous genes involved in the EMT. CONCLUSIONS: These findings demonstrate that miR-145 functions as tumor suppressor in RCC, suggesting that miR-145 may be a potential therapeutic target for RCC.
Authors: Eugene Berezikov; Victor Guryev; José van de Belt; Erno Wienholds; Ronald H A Plasterk; Edwin Cuppen Journal: Cell Date: 2005-01-14 Impact factor: 41.582
Authors: Eugene Izumchenko; Mahendra K Singh; Olga V Plotnikova; Nadezhda Tikhmyanova; Joy L Little; Ilya G Serebriiskii; Sachiko Seo; Mineo Kurokawa; Brian L Egleston; Andres Klein-Szanto; Elena N Pugacheva; Richard R Hardy; Marina Wolfson; Denise C Connolly; Erica A Golemis Journal: Cancer Res Date: 2009-09-08 Impact factor: 12.701
Authors: Jonathan Oliner; Hosung Min; Juan Leal; Dongyin Yu; Shashirekha Rao; Edward You; Xiu Tang; Haejin Kim; Susanne Meyer; Seog Joon Han; Nessa Hawkins; Robert Rosenfeld; Elyse Davy; Kevin Graham; Frederick Jacobsen; Shirley Stevenson; Joanne Ho; Qing Chen; Thomas Hartmann; Mark Michaels; Michael Kelley; Luke Li; Karen Sitney; Frank Martin; Ji-Rong Sun; Nancy Zhang; John Lu; Juan Estrada; Rakesh Kumar; Angela Coxon; Stephen Kaufman; James Pretorius; Sheila Scully; Russ Cattley; Marc Payton; Steve Coats; Linh Nguyen; Binodh Desilva; Anthony Ndifor; Isaac Hayward; Robert Radinsky; Tom Boone; Richard Kendall Journal: Cancer Cell Date: 2004-11 Impact factor: 31.743
Authors: Jonathan D Kenyon; Olga Sergeeva; Rodrigo A Somoza; Ming Li; Arnold I Caplan; Ahmad M Khalil; Zhenghong Lee Journal: Tissue Eng Part A Date: 2018-05-24 Impact factor: 3.845